Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819656) titled 'Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma' on Sept. 9.

Study Type: Observational

Primary Sponsor: Nanfang Hospital, Southern Medical University

Condition: Nasopharyngeal Carcinoma (NPC) Myelosuppression

Recruitment Status: Recruiting

Date of First Enrollment: August 26, 2026

Target Sample Size: 1782

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07819656

Published by HT Digital Content Services with permission from Health Daily Digest....